Targeting immunosuppressive classical monocytes prevents immunotherapy resistance

Authors

B. Leticia Rodriguez, The University of Texas MD Anderson Cancer Center
Limo Chen, The University of Texas MD Anderson Cancer Center
Yanli Li, The University of Texas MD Anderson Cancer Center
Shucheng Miao, The University of Texas MD Anderson Cancer Center
David H. Peng, The University of Texas MD Anderson Cancer Center
Jared Fradette, The University of Texas MD Anderson Cancer Center
Lixia Diao, The University of Texas MD Anderson Cancer Center
Jessica Marie Konen, The University of Texas MD Anderson Cancer Center
Aparna Padhye, The University of Texas MD Anderson Cancer Center
Laura Gibson, The University of Texas MD Anderson Cancer Center
Joshua K. Ochieng, The University of Texas MD Anderson Cancer Center
Xiaofei Zhou PhD, The University of Texas MD Anderson Cancer Center
Jing Wang, The University of Texas MD Anderson Cancer Center
Don Gibbons, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00077

Publication Date

2022

Department

Thoracic Head and Neck Medical Oncology

Research Category

Unleashing the Immune System to Develop Therapeutic Strategies

Recommended Citation

Rodriguez, B. Leticia; Chen, Limo; Li, Yanli; Miao, Shucheng; Peng, David H.; Fradette, Jared; Diao, Lixia; Konen, Jessica Marie; Padhye, Aparna; Gibson, Laura; Ochieng, Joshua K.; Zhou, Xiaofei PhD; Wang, Jing; and Gibbons, Don, "Targeting immunosuppressive classical monocytes prevents immunotherapy resistance" (2022). Leading Edge of Cancer Research Symposium. 54.
doi:https://doi.org/10.52519/00077